North America Startup Funding Rounds
Startups raising capital across North America. Compare the businesses, funding stages and investors active in the region.
- Rounds
- 2,305 Jan 1 – Oct 25, 2026
- Disclosed funding
- $211.5B 1912 disclosed amounts
- Median round
- $23.3M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| N NavidenceCompany profile Provides AI-native platform with standardized computable definitions of diseases and outcomes for real-world evidence research Provides AI-native platform with standardized computable definitions of diseases and outcomes for real-world evidence research | Undisclosed | Seed | Healthtech | United States | Investors | |
| K Develops an AI-agent platform for automating enterprise workflows. | Undisclosed | Strategic GrowthUndisclosed | AI | United States | Investors | |
| F Provides AI platform for insurance brokerages to modernize workflows | $25M | Seed+Series AUndisclosed | Fintech | United States | Investors | |
| NA Provides a privacy-first platform for outcome-driven college counseling | $3.2M | Seed | Edtech | United States | Investors | |
| G GridlineCompany profile Provides a turnkey alternatives management platform for private market investing Provides a turnkey alternatives management platform for private market investing | $18.5M | Series A | Fintech | United States | Investors | |
| C ChamelioCompany profile Chamelio provides AI contract review, negotiation and legal-workflow tools for in-house legal teams. Chamelio provides AI contract review, negotiation and legal-workflow tools for in-house legal teams. | $10M | Seed | Enterprise software | United States | Investors | |
| M Automates SOX testing and internal audit workflows with agentic AI | $4.2M | Seed | AI | United States | Investors | |
 AntheiaCompany profile Antheia manufactures pharmaceutical ingredients through biosynthesis, using controlled fermentation to supply drugmakers with key starting materials and active ingredients. Antheia manufactures pharmaceutical ingredients through biosynthesis, using controlled fermentation to supply drugmakers with key starting materials and active ingredients. | $24M | Series C second closeSeries C+ | Biotech | United States | Investors | |
| FA Provides AI observability and security platform for enterprises | $30M | Series CSeries C+ | AI | United States | Investors | |
| V AI-native property operations platform for commercial real estate | $22M | Series B | Proptech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1Y Combinator (YC)
Tractian, Blacksmith, Databuddy Analytics
133rounds3led - 2Andreessen Horowitz (a16z)
ASI, Eka Robotics, Town
98rounds19led - 3General Catalyst
Tractian, Different, Baba
70rounds7led - 4Alumni Ventures
Maxinsights, Daytona, Chariot Claims
60rounds0led - 5Khosla Ventures
Arda Industries, Tolan
59rounds6led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.